Hermann Toplak

Summary

Affiliation: Medical University of Graz
Country: Austria

Publications

  1. ncbi request reprint [Metabolic syndrome--a high cardiovascular risk?]
    Hermann Toplak
    Ambulanz für Diabetes und Stoffwechsel, Medizinische Universitatsklinik, Leopold Auenbrugger Universität, Auenbruggerplatz 15, 8036 Graz, Osterreich
    Acta Med Austriaca 31:63-6. 2004
  2. ncbi request reprint X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance
    H Toplak
    Department of Medicine, Medical University, Graz, Austria
    Diabetes Obes Metab 7:699-708. 2005
  3. ncbi request reprint Efficacy and safety of topiramate in combination with metformin in the treatment of obese subjects with type 2 diabetes: a randomized, double-blind, placebo-controlled study
    H Toplak
    Department of Medicine, Institute for Diabetes and Metabolism, Medical University, Graz, Austria
    Int J Obes (Lond) 31:138-46. 2007
  4. ncbi request reprint Evaluation of a new DNA test compared with the lactose hydrogen breath test for the diagnosis of lactase non-persistence
    Christoph Hogenauer
    Department of Internal Medicine, Medical University of Graz, Austria
    Eur J Gastroenterol Hepatol 17:371-6. 2005
  5. doi request reprint A pilot study of mobile phone-based therapy for obese patients
    Juergen Morak
    Department of Biomedical Engineering, Division of E health Systems, Austrian Research Centers GmbH ARC, Graz, Austria
    J Telemed Telecare 14:147-9. 2008
  6. doi request reprint Treatment modalities of obesity: what fits whom?
    Vojtech Hainer
    Institute of Endocrinology, Narodni 8, 116 94 Prague 1, Czech Republic
    Diabetes Care 31:S269-77. 2008
  7. ncbi request reprint Effects of orlistat therapy on plasma concentrations of oxygenated and hydrocarbon carotenoids
    Isabella Sundl
    Human Nutrition and Metabolism Research and Training Center Graz, Institute of Molecular Biosciences, Karl Franzens University, 8010 Graz, Austria
    Lipids 41:113-8. 2006

Collaborators

Detail Information

Publications7

  1. ncbi request reprint [Metabolic syndrome--a high cardiovascular risk?]
    Hermann Toplak
    Ambulanz für Diabetes und Stoffwechsel, Medizinische Universitatsklinik, Leopold Auenbrugger Universität, Auenbruggerplatz 15, 8036 Graz, Osterreich
    Acta Med Austriaca 31:63-6. 2004
    ..We suggest that the risk should be evaluated in the context of body mass index (BMI) and especially of waist circumference which could be THE central intervention factor in the treatment of our patients...
  2. ncbi request reprint X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance
    H Toplak
    Department of Medicine, Medical University, Graz, Austria
    Diabetes Obes Metab 7:699-708. 2005
    ..To determine the effect of two different levels of energy deficit on weight loss in obese patients treated with orlistat...
  3. ncbi request reprint Efficacy and safety of topiramate in combination with metformin in the treatment of obese subjects with type 2 diabetes: a randomized, double-blind, placebo-controlled study
    H Toplak
    Department of Medicine, Institute for Diabetes and Metabolism, Medical University, Graz, Austria
    Int J Obes (Lond) 31:138-46. 2007
    ..To investigate the efficacy and safety of topiramate in obese subjects with type 2 diabetes treated with metformin...
  4. ncbi request reprint Evaluation of a new DNA test compared with the lactose hydrogen breath test for the diagnosis of lactase non-persistence
    Christoph Hogenauer
    Department of Internal Medicine, Medical University of Graz, Austria
    Eur J Gastroenterol Hepatol 17:371-6. 2005
    ..We therefore compared the value of DNA testing for this variant (DNA test) with the lactose hydrogen breath test (H2 test), which is the clinical standard for the diagnosis of lactase non-persistence...
  5. doi request reprint A pilot study of mobile phone-based therapy for obese patients
    Juergen Morak
    Department of Biomedical Engineering, Division of E health Systems, Austrian Research Centers GmbH ARC, Graz, Austria
    J Telemed Telecare 14:147-9. 2008
    ..The pilot study showed that mobile phones can be utilized as patient terminals for therapy in patients suffering from obesity...
  6. doi request reprint Treatment modalities of obesity: what fits whom?
    Vojtech Hainer
    Institute of Endocrinology, Narodni 8, 116 94 Prague 1, Czech Republic
    Diabetes Care 31:S269-77. 2008
    ..Centers of excellence in obesity management represented by multidisciplinary teams should provide comprehensive programs for the treatment of obesity derived from evidence-based medicine...
  7. ncbi request reprint Effects of orlistat therapy on plasma concentrations of oxygenated and hydrocarbon carotenoids
    Isabella Sundl
    Human Nutrition and Metabolism Research and Training Center Graz, Institute of Molecular Biosciences, Karl Franzens University, 8010 Graz, Austria
    Lipids 41:113-8. 2006
    ..In conclusion, even though weight loss was not significant, orlistat therapy was associated with significant decreases in plasma concentrations of the highly lipophilic hydrocarbon carotenoids, alpha- and beta-carotene...